Active — Not RecruitingNot Applicable

RUDRA Registry (Real-World Clinical Registry for Patients With Recurrent Pericarditis)

Russia100 participantsStarted 2024-09-30

Plain-language summary

А multicenter, non-interventional real world clinical registry of patients with recurrent pericarditis. The main goal of the registry is to epidemiologically assess the pattern, clinical outcomes, and approaches to therapy in patients with recurrent pericarditis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Men or women 18 years of age or older at the time of data recording or pericarditis debut;
✓. Presence of one of the following conditions:

Exclusion criteria

✕. Age below 18 years at the time of inclusion in the registry or debut of pericarditis;
✕. Specialist-confirmed secondary genesis of RP (infectious, autoimmune, neoplastic, metabolic, traumatic, iatrogenic, etc.); 2. Manifestations and complications of myocarditis, various diseases of thoracic organs, systemic diseases, cardiac surgery, radiation therapy, tuberculosis, etc.);
✕. lack of possibility of screening examination and dynamic follow-up;
✕. Organ/tissue transplantation less than 5 years prior to study inclusion or debut of pericarditis;
✕. Oncologic disease less than 3 years prior to study inclusion or pericarditis debut;
✕. Chemotherapy with anthracycline-type drugs at the time of pericarditis debut;
✕. Administration of amphetamine-type drugs at the time of pericarditis debut;
✕. Cardiac/pericardial surgery in the last 6 months prior to study inclusion or pericarditis debut;

What they're measuring

Number of pericarditis recurrences

Timeframe: 6, 12, 18, 24, 30, 36 month

Trial details

NCT IDNCT06517966

SponsorEurasian Association of Therapists

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-07-30

View on ClinicalTrials.gov More Pericarditis trials